CHIP/STUB1 Ubiquitin Ligase Functions as a Negative Regulator of ErbB2 by Promoting Its Early Post-Biosynthesis

Haitao Luan1,2,3, Tameka A Bailey1, Robert J Clubb1

  • 1Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, NE 68198, USA.

Cancers
|August 27, 2021
PubMed

Insights

The C-terminus of HSC70-Interacting protein (CHIP) degrades overexpressed ErbB2 (HER2) in breast cancer cells. Loss of CHIP increases ErbB2, making cancers responsive to combined Trastuzumab and endoplasmic reticulum stress therapies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Overexpression of ErbB2 (HER2) drives oncogenesis in a significant portion of invasive breast cancers.
  • Cell surface expression of ErbB2 is crucial for its oncogenic activity, but the mechanisms regulating its display are not fully understood.
  • ErbB2 stability and function depend on the HSP90 molecular chaperone.

Purpose of the Study:

  • To investigate the role of CHIP (C-terminus of HSC70-Interacting protein) in regulating cell surface ErbB2 levels.
  • To identify novel mechanisms controlling ErbB2 cell surface expression in breast cancer.
  • To explore therapeutic strategies targeting ErbB2-overexpressing breast cancers with reduced CHIP expression.

Main Methods:

  • Utilized knockdown and overexpression studies to assess CHIP's effect on ErbB2.
  • Investigated the ubiquitin/proteasome-dependent degradation pathway in the endoplasmic reticulum and Golgi.
  • Analyzed endoplasmic reticulum stress responses in breast cancer cells with varying CHIP expression levels.
  • Evaluated the synergistic effects of Bortezomib and Trastuzumab on cancer cell proliferation.

Main Results:

  • CHIP targets newly synthesized, HSP90/HSC70-associated ErbB2 for degradation, thereby negatively regulating cell surface ErbB2 levels.
  • Loss of CHIP expression in ErbB2-overexpressing breast cancers correlates with increased endoplasmic reticulum stress.
  • Combined treatment with Bortezomib and Trastuzumab demonstrated synergistic inhibition of ErbB2-overexpressing breast cancer cell proliferation.

Conclusions:

  • CHIP acts as a novel negative regulator of cell surface ErbB2 expression in breast cancer.
  • Reduced CHIP expression may identify ErbB2-overexpressing breast cancers that are sensitive to combined Trastuzumab and endoplasmic reticulum stress-inducing agents.
  • These findings offer new insights into ErbB2 regulation and suggest a potential therapeutic approach for specific breast cancer subtypes.

Related Concept Videos

Regulated Protein Degradation02:58

Regulated Protein Degradation

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
7.9K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.3K
Hedgehog Signaling Pathway02:33

Hedgehog Signaling Pathway

The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
7.8K
Export of Misfolded Proteins out of the ER01:32

Export of Misfolded Proteins out of the ER

After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
4.3K
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.7K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
36.7K